Salute e Benessere

Sectra enterprise imaging in the cloud to foster collaboration across 150 sites…

"I am honored by the trust MSSS Québec has placed in us in helping them enhance patient care across the province. This opportunity represents a significant milestone for Sectra in Canada and highlights our commitment to delivering innovative healthcare solutions. As we enter this exciting phase, we are excited about the possibilities that lie ahead. We will leverage our knowledge in deploying solutions for multi-site health systems to contribute to MSSS Québec's aim of significantly…
PR Newswire
27/09/2024

AMD Drugs Market to Hit USD 17.37 Billion by 2029 with 10.7% CAGR |…

Browse in-depth TOC on "Age-related Macular Degeneration (AMD) Drugs Market" Browse in-depth TOC on "Age-related Macular Degeneration (AMD) Drugs Market" 378 - Tables 54 - Figures 336 - Pages Based on molecules,the global Age-Related Macular Degeneration (AMD) drugs market has been segmented into Ranibizumab, Aflibercept, Faricimab, Pegcetacoplan, and other molecules including conbercept, brolucizumab, avacincaptad pegol, and bevacizumab-gamma among others. In 2023,...
PR Newswire
27/09/2024

Point-of-Care Diagnostics Market Surges to USD 68.8 Billion by 2030, Propelled…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=482155 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=482155 Browse in-depth TOC onPoint-of-Care Diagnostics Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Point-of-Care Diagnostics Market Overview Market Drivers Fueling Growth in the Point-of-Care Diagnostics Market Rising Demand for Rapid Testing The increasing...
PR Newswire
27/09/2024

Press Release: Dupixent approved in the US as the first-ever biologic medicine…

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype Following recent approvals in the EU and China, the US approval is based on two landmark phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also showed improvements in lung function and health-related quality of life...
Nasdaq GlobeNewswire
27/09/2024

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize…

The tool simplifies and streamlines the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history. This not only improves efficiency and communication in medical oversight, but also elevates patient safety, differentiating MSR as a smarter and unique solution. The tool simplifies and streamlines the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning,...
PR Newswire
27/09/2024

SciBase announces sale of Nevisense to NIH (US)

"The fact that this prestigious governmental institution has chosen to use Nevisense in their research speaks volumes about the credibility and reliability of our product," says Pia Renaudin, CEO of SciBase. "The skin barrier research market is experiencing a rapid rise in interest, and the research in this space can directly improve the lives of millions of people worldwide. We are confident that the use of our device by the NIH will lead to groundbreaking discoveries and…
PR Newswire
27/09/2024

Press Release: Dupixent approved in China as the first-ever biologic medicine…

Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function, and also improved health-related quality of lifeCOPD is the most prevalent chronic respiratory disease in China, and is a priority within the government's Healthy China 2030 public health...
Nasdaq GlobeNewswire
27/09/2024

Sultan bin Ahmed lays foundation stone for Al Reeh Al Mursala Clinic in…

The Chairman of the Sharjah Media Council noted that the establishment of the clinic, which will feature a range of medical specializations, as well as repairs to the drinking water system in October Village, Kyrgyzstan, is part of the charitable initiatives that got underway in Aswan, Egypt, in July, which aims to help the greatest number of sick and destitute people worldwide. Sheikh Sultan bin Ahmed confirmed that the humanitarian medical campaigns would go on in other countries. The...
PR Newswire
27/09/2024

Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable…

Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which everyone can live a healthy and productive life, free from the preventable suffering, stigma, disability, and death caused by non-communicable diseases (NCDs). The start of the partnership was announced alongside the United Nations Global Assembly in New York.NCDs are a major global health issue. These diseases, which are not transmitted from person to person, cause 41...
Nasdaq GlobeNewswire
27/09/2024

25 Years of Innovation and Excellence: Alma Celebrates Silver Anniversary at the…

The company, which started as an energy-based device provider, quickly climbed to the top of the industry, revolutionizing treatment paradigms in various aesthetic areas and setting new benchmarks in the medical aesthetic field in terms of both clinical excellence and innovative breakthroughs. The company, which started as an energy-based device provider, quickly climbed to the top of the industry, revolutionizing treatment paradigms in various aesthetic areas and setting new benchmarks in…
PR Newswire
27/09/2024

Anbogen Announces Drug Supply Collaboration with BeiGene to Evaluate Combination…

ABT-301, a novel HDAC inhibitor, has shown promising safety and pharmacokinetic profiles in a prior Phase 1 study as a single agent. Preclinical studies indicate that ABT-301 enhances the effectiveness of anti-PD-1/anti-PD-L1 therapies by increasing CD8+ cytotoxic T cells and decreasing monocytic myeloid-derived suppressor cells within both the tumor and circulation, and inhibiting angiogenesis. These immune response enhancements may broaden the efficacy of ICIs in colorectal cancer…
PR Newswire
27/09/2024

Nexstim Receives Order for NBS System 5 in Finland

Press release, Helsinki, 27 September 2024 at 10 AM (EEST) Nexstim Receives Order for NBS System 5 in Finland Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received order from a Finnish hospital for an NBS System 5. The customer is new to Nexstim.The Nexstim Navigated Brain Stimulation (NBS) System 5 is indicated for non-invasive mapping of the primary motor cortex of the brain to its cortical gyrus. The system provides information that may be used in the assessment…
Nasdaq GlobeNewswire
27/09/2024

Photocure establishes Named Patient Program to provide access to Hexvix in South…

"Without this NPP, BLC with Hexvix would not otherwise be available to bladder cancer patients in South Africa. Photocure is committed to ensuring global access to Hexvix as part of its sustainability goals," said Dan Schneider, President and CEO of Photocure. "We see this program as a stepstone to trialing various ways in which Hexvix can be made available to patients and urologists in countries where BLC equipment is already accessible." "Without this NPP, BLC with…
PR Newswire
27/09/2024

Casino Group: Real estate asset sales

Casino Group sells over €200m of commercial real estate assets to Tikehau Capital Paris, 27 September 2024Following the signature in June 2024 of an agreement with Tikehau Capital covering a portfolio of 30 real estate assets, Casino Group announced that on Thursday, 26 September 2024 it had finalized the sale of 26 of these, for a net selling price of over 200 million euros, excluding subsequentearn-outs. The sale of the remaining assets, provided for in the agreements, will be...
Nasdaq GlobeNewswire
27/09/2024

Information on the total number of voting rights and shares

REGULATED INFORMATIONInformation on the total number of voting rights and sharesMont-Saint-Guibert(Belgium), September 27, 2024 , 08:05 am CET / 2:05 am ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 5,907,711.21 Total number of securities carrying voting rights: 34,389,015 (all ordinary...
Nasdaq GlobeNewswire
27/09/2024

Publication relating to transparency notifications

REGULATED INFORMATIONPublication relating to transparency notificationsMont-Saint-Guibert(Belgium), September 27, 2024 , 8.00am CET / 2.00am ET –In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.BlackRock, Inc.On September 24, 2024, Nyxoah received a transparency notification from...
Nasdaq GlobeNewswire
27/09/2024

Medit Expands Intraoral Scanner Presence in Slovenia and the Balkans

Visitors to Medit's booth will explore how these scanners can enhance diagnostic accuracy and operational efficiency in modern dental practices. They will also have the opportunity to engage with Medit's experts and discover how its technology supports clinicians and technicians in delivering high-quality dental services. Visitors to Medit's booth will explore how these scanners can enhance diagnostic accuracy and operational efficiency in modern dental practices. They will also have the...
PR Newswire
27/09/2024

EADV Congress 2024: New research confirms link between perceived stress and…

In the study, psoriatic lesions were induced in healthy human skin xenografts on mice (n=25) through the injection of autologous, in vitro IL-2-preactivated peripheral blood mononuclear cells. After achieving lesion remission with topical dexamethasone, the mice were exposed to either sonic (sound) or sham stress for 24 hours. The recurrence of psoriatic lesions was then tracked over the following 14 days. In the study, psoriatic lesions were induced in healthy human skin xenografts on mice...
PR Newswire
27/09/2024

Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6%…

Key Takeaways from the Hormone Replacement Therapy Market Report Key Takeaways from the Hormone Replacement Therapy Market Report To read more about the latest highlights related to the hormone replacement therapy market, get a snapshot of the key highlights entailed in theGlobal Hormone Replacement Therapy Market Report Hormone Replacement Therapy Overview Hormone replacement therapy (HRT) is a medical treatment commonly used to alleviate symptoms associated with menopause,...
PR Newswire
26/09/2024

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement COPENHAGEN, Denmark; September 26, 2024 –Genmab A/S(Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the...
Nasdaq GlobeNewswire
26/09/2024

AI in Life Sciences Market Poised for Explosive Growth with 27.9% CAGR Through…

The global artificial intelligence (AI) in the life sciences market is witnessing significant growth, driven by advancements in AI technologies and their increasing adoption across the life sciences sector. This report provides a comprehensive analysis of the market size, estimating both current and historical revenues segmented by products, applications, end users, and regions. By examining these factors, the report offers insights into the evolving landscape of AI in life sciences…
PR Newswire
26/09/2024

Global Theranostics Market to Triple, Reaching $12.7 Billion by 2029

The theranostics market is robust and dynamic, characterized by a diverse array of companies offering comprehensive solutions. Major players in the market, including leaders in diagnostics and therapeutics, are profiled extensively, detailing their revenues, product portfolios, and recent strategic initiatives. The competitive landscape is thoroughly examined alongside market trends and key dynamics such as drivers, restraints, and opportunities. Segmented by product type, theranostics offerings…
PR Newswire
26/09/2024

LiveWell Awarded Frost & Sullivan's 2024 Global Customer Value Leadership Award…

In their report, Frost & Sullivan state that LiveWell provides world-class digital health and well-being solutions to balance physical, mental, social, and financial health through its user-friendly app. LiveWell offers a wide range of tools that include mood and stress tracking; mental health support; and services offering support on a range of wellness topics. LiveWell is one of many pioneers addressing significant challenges to the mental and behavioral health industry, such as stigma…
PR Newswire
26/09/2024

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib…

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and bone marrow reconstitution potential of patient derived hematopoietic stem cellsIn vitro data also demonstrated improved ability to differentiate to erythroid cells, supporting potential for improvement in biomarkers of anemiaHAIFA, Israel, Sept.26, 2024...
Nasdaq GlobeNewswire
26/09/2024
Altri  Comunicati